The Substance Use Disorder Committee is responsible for developing tools and educational resources for pharmacists. Additionally, the Committee assists the Government Affairs Committee when information is needed to support comment letters or issue briefs related to regulatory or legislative actions or possible actions in the area of substance use disorders. (Meets: Virtually 1-hour monthly and in-person at Annual Meeting, Time Commitment: Average of 2-3 hours per month or 25-30 hours approximately over course of the year)
1. Education
|
a. Outreach to potential partners about collaboration on an Opioid Use Disorders curriculum for pharmacists should it be determined that it has value in the context of the revised DEA-MATE Training requirements for DEA license renewal. |
b. Recommend partner organizations to involve in the planning and/or co-sponsorship of other educational activities. |
c. Continue organizational involvement in PCSS as a conduit to education and mentoring in the area of SUD. |
d. Implement the 2024 SUD Scoop case-based series and make recommendations for 2025 related to this and other educational activities. |
2. Resources
|
a. Assess the need for additional toolkits and other resources and, if the need is determined, develop and implement accordingly. |
b. Through a meeting with RPDs, explore how AAPP can support pharmacy residencies in enhancing the experience they are able to provide in substance use disorders. |
c. Proactively identify members to work with to submit proposals for SUD conferences targeted through the AAPP Ambassador program and, where appropriate, craft specific proposals. |
3. Advocacy
|
a. Support the Government Affairs and Professional Affair Committee efforts (comment letters, conference proposals, other deliverables, projects) where requested. |
b. Recommend papers to the Commission on Innovation and Advancement. |